Health & Nutrition

bg
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial

Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage...

Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in...

bg
Catalyst calendar: Here's a look at major events that could propel these 7 stocks higher

Catalyst calendar: Here's a look at major events that could...

AI tech stocks have been on the rage on Wall Street. But here are some events that...

bg
Neuralink competitor Paradromics gears up to test its brain implant on humans

Neuralink competitor Paradromics gears up to test its brain...

Neurotech startup Paradromics will be putting its brain implant on trial next year,...

bg
FDA OKs first menthol e-cigarettes, citing potential to help adult smokers

FDA OKs first menthol e-cigarettes, citing potential to...

The decision lends new credibility to vaping companies’ longstanding claim that...

bg
Eli Lilly expects FDA decision on weight loss drug Zepbound for sleep apnea as early as end of the year

Eli Lilly expects FDA decision on weight loss drug Zepbound...

Some patients with obstructive sleep apnea and obesity who took the highest dose...

bg
What Should We Eat? 

What Should We Eat? 

Here is a review of reviews on the health effects of animal foods versus plant foods....

bg
FDA approves Merck vaccine designed to protect adults from bacteria that can cause pneumonia, serious infections

FDA approves Merck vaccine designed to protect adults from...

Merck's shot protects against 21 strains of that bacteria to prevent a severe form...

bg
Healthy Returns: More U.S. employers are now covering GLP-1s for weight loss

Healthy Returns: More U.S. employers are now covering GLP-1s...

More U.S. employers are covering GLP-1s for weight loss, according to a survey....

bg
What Should We Drink? 

What Should We Drink? 

Here is a review of reviews on the health effects of tea, coffee, milk, wine, and...

bg
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi

How Eli Lilly is managing soaring demand for GLP-1s, according...

Ashkenazi has been key to managing the windfall in revenue and wave of investor...